WebDisclosure WebDisclosure
Basculer en Français
10387 Companies
216927 Keywords
146620 Articles
114862 Press releases
Headlines Articles Press releases Newron Pharmaceuticals S.p.A. Remove
  1. Home
  2. Companies
  3. Newron Pharmaceuticals S.p.A.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 03/17/2023 at 07:00, 3 years 1 month ago

    Newron to present at the 31st European Congress of Psychiatry  

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 03/14/2023 at 07:00, 3 years 1 month ago

    Newron announces 2022 financial results and provides outlook for 2023

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 02/16/2023 at 07:00, 3 years 2 months ago

    Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 01/03/2023 at 07:00, 3 years 4 months ago

    Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia

    Logo of Newron Pharmaceuticals S.p.A.
Previous page
1 ... 10 11
Accesswire
  • Published on 05/13/2026 at 00:00, 1 hour 25 minutes ago

    Onco-Innovations Announces Initiation of Research Collaboration within PROmAI

  • Published on 05/12/2026 at 23:35, 1 hour 50 minutes ago

    Infield Minerals Closes $1.25 Million Financing

  • Published on 05/12/2026 at 21:55, 3 hours 30 minutes ago

    UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures

  • Published on 05/12/2026 at 21:42, 3 hours 43 minutes ago

    Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026

  • Published on 05/12/2026 at 14:30, 10 hours 55 minutes ago

    Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 05/12/2026 at 23:47, 1 hour 37 minutes ago

    Nebius welcomes Clarifai’s core team and licenses inference IP to strengthen Nebius Token Factory

  • Published on 05/12/2026 at 22:25, 2 hours 59 minutes ago

    Evotec SE Successfully Placed €116.1 Million Convertible Bonds

  • Published on 05/12/2026 at 20:21, 5 hours 3 minutes ago

    Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri

  • Published on 05/12/2026 at 19:35, 5 hours 49 minutes ago

    AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results

  • Published on 05/12/2026 at 19:35, 5 hours 50 minutes ago

    2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy

View all EQS
Les Echos
  • Published on 05/12/2026 at 18:15, 7 hours 10 minutes ago

    AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026

  • Published on 05/12/2026 at 18:15, 7 hours 10 minutes ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026

  • Published on 05/12/2026 at 18:10, 7 hours 15 minutes ago

    imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026

  • Published on 05/12/2026 at 18:10, 7 hours 15 minutes ago

    imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026

  • Published on 05/12/2026 at 17:50, 7 hours 35 minutes ago

    Damartex fait évoluer sa gouvernance et engage une réflexion stratégique autour de ses activités

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy